cerrar
Tagged with Research,

Speeding up the Search for Safe & Effective COVID-19…
IFPMA Director General Thomas B. Cueni shares the outcomes of a recent high level pharma industry media briefing on the search for a COVID-19…

Company Spotlight: Junshi Biosciences – Lilly’s Partner on…
Established in December 2012, in less than a decade, Chinese biotech Junshi Biosciences has already transformed itself into a publicly-listed…

Chae-Ok Yun – Founder, CEO & CTO, GeneMedicine
Founder, CEO and CTO Dr Chae-Ok Yun introduces GeneMedicine, a pioneer of the oncolytic virus approach in gene therapy. Dr Yun outlines the…

Marijke Eyssen – Interim Director General, Belgian Health…
Marijke Eyssen of the Belgian Health Care Knowledge Centre (KCE) introduces the institution’s mission, core values, how it chooses areas of…

Roman Grunt – CEO, Quinta Analytica, Czech Republic
Roman Grunt, CEO of Quinta Analytica, gives us an overview of the activities of how the Czech firm has managed to attract customers across the country…

Dirk Reyn – President, Flanders.bio, Belgium
Dirk Reyn of Flanders.bio highlights what the Flanders region has to offer the life sciences and biotech industries in terms of research…

Czech Clinical Trials: Finding the Niches
The Czech Republic boasts a solid clinical research infrastructure and a supportive regulatory environment, meaning that it stands out as one of…

The UK: The G7’s Hottest Life Science Investment Destination?
With Brexit now confirmed, the UK government has been playing up the country’s scientific credentials. The aim is to cement the UK’s position as…

Olga Starobová – Medical Director, Medical Management and…
Olga Starobová, medical director of Syneos Health Czech Republic, walks us through the steps put in place to ensure successful synergies during the…

Data – The Catch-All Solution for Costly Clinical Trials?
With clinical trials having become extremely expensive to conduct, industry buzz around the potential of data and artificial intelligence (AI) to…

China: A New Decade
2019 was a landmark year for the Chinese healthcare industry.* Since the publication of the ‘Healthy China 2030’ blueprint in 2016 by the Chinese…

Would the Last Pharmaceutical Investor in Europe Please Turn the…
EFPIA’s Nathalie Moll highlights how Europe can reverse its decline in the global medical research standings and once again make the continent a…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here